P10637 (TAU_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 148.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Microtubule-associated protein tau Alternative name(s): Neurofibrillary tangle protein Paired helical filament-tau Short name=PHF-tau | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 733 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by tau localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. |
| Subunit structure | Interacts with SQSTM1 when polyubiquitinated By similarity. Interacts with PSMC2 through SQSTM1. Interacts with FKBP4. Binds to CSNK1D By similarity. Interacts with SGK1 By similarity. Ref.12 |
| Subcellular location | Cytoplasm › cytosol. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm › cytoskeleton. Cell projection › axon. Note: Mostly found in the axons of neurons, in the cytosol and in association with plasma membrane components. |
| Tissue specificity | Expressed in neurons and at a lower level in the liver and kidney. Isoform PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system. |
| Developmental stage | Shorter forms or low molecular weight tau (lMW-tau) are generally expressed at early development stages and longer forms or high molecular weight tau (hMW-tau) in the adult brain. |
| Domain | The tau/MAP repeat binds to tubulin. Type I isoforms contain 3 repeats while type II isoforms contain 4 repeats. |
| Post-translational modification | Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome By similarity. Phosphorylation at various serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1: CDK1, CDK5, GSK3, MAPK) (a few sites per protein in interphase, more in mitosis), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1 or MARK2), causing detachment from microtubules, and their disassembly. Phosphorylated by PHK By similarity. Phosphorylation at Ser-554 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylation at Ser-188 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons By similarity. Ref.9 Ref.13 Ref.15 |
| Involvement in disease | May be involved in the pathogenesis of cytoplasmic inclusions (as Mallory bodies) in livers of mice chronically intoxicated with Griseofulvin or DDC (3,5-diethoxycarbonyl-2,4-dihydrocollidine), a model for human alcoholic hepatitis. Alteration of Tau (abnormal phosphorylation and cross-linking) could contribute to Mallory bodies formation and disturbance of microtubule function in alcoholic liver disease. |
| Sequence similarities | Contains 4 Tau/MAP repeats. |
Ontologies
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. Isoforms differ from each other by the presence or absence of up to 5 of the 14 exons. One of these optional exons contains the additional tau/MAP repeat. Two different C-termini are obtained either by the retention or the splicing of intron 13/14. | ||||||
| Isoform PNS-Tau (identifier: P10637-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Tau-A (identifier: P10637-2) The sequence of this isoform differs from the canonical sequence as follows: 114-350: Missing. 368-433: Missing. | ||||||
| Isoform Tau-B (identifier: P10637-3) The sequence of this isoform differs from the canonical sequence as follows: 34-91: Missing. 114-350: Missing. 368-433: Missing. 567-597: Missing. 733-733: L → KAALLSSQVWNYSHDLATITDLGL | ||||||
| Isoform Tau-C (identifier: P10637-4) The sequence of this isoform differs from the canonical sequence as follows: 34-91: Missing. 114-350: Missing. 368-433: Missing. 567-597: Missing. | ||||||
| Isoform Tau-D (identifier: P10637-5) The sequence of this isoform differs from the canonical sequence as follows: 34-91: Missing. 114-350: Missing. 368-433: Missing. | ||||||
| Isoform Tau-E (identifier: P10637-6) The sequence of this isoform differs from the canonical sequence as follows: 34-91: Missing. 92-113: Missing. 114-350: Missing. 368-433: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||||
| Chain | 2 – 733 | 732 | Microtubule-associated protein tau | PRO_0000072742 | |||||||
Regions | |||||||||||
| Repeat | 536 – 566 | 31 | Tau/MAP 1 | ||||||||
| Repeat | 567 – 597 | 31 | Tau/MAP 2 | ||||||||
| Repeat | 598 – 628 | 31 | Tau/MAP 3 | ||||||||
| Repeat | 629 – 660 | 32 | Tau/MAP 4 | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | ||||||||
| Modified residue | 18 | 1 | Phosphotyrosine; by FYN By similarity | ||||||||
| Modified residue | 35 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 100 | 1 | Phosphothreonine Ref.17 | ||||||||
| Modified residue | 188 | 1 | Phosphoserine; by SGK1 By similarity | ||||||||
| Modified residue | 445 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 457 | 1 | Phosphothreonine Ref.16 | ||||||||
| Modified residue | 467 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 470 | 1 | Phosphoserine Ref.17 | ||||||||
| Modified residue | 473 | 1 | Phosphothreonine Ref.17 | ||||||||
| Modified residue | 489 | 1 | Phosphotyrosine Ref.17 | ||||||||
| Modified residue | 490 | 1 | Phosphoserine Ref.11 Ref.16 | ||||||||
| Modified residue | 491 | 1 | Phosphoserine Ref.11 Ref.16 Ref.18 | ||||||||
| Modified residue | 494 | 1 | Phosphoserine; by CK1, PDPK1 and TTBK1 Ref.11 Ref.16 Ref.17 | ||||||||
| Modified residue | 497 | 1 | Phosphothreonine; by CK1 and PDPK1 Ref.16 Ref.17 | ||||||||
| Modified residue | 504 | 1 | Phosphothreonine; by BRSK1, BRSK2, DYRK2 and PDPK1 By similarity | ||||||||
| Modified residue | 506 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 509 | 1 | Phosphothreonine By similarity | ||||||||
| Modified residue | 523 | 1 | Phosphothreonine; by GSK3-beta and PDPK1 By similarity | ||||||||
| Modified residue | 527 | 1 | Phosphoserine Ref.14 | ||||||||
| Modified residue | 529 | 1 | Phosphoserine; by PHK By similarity | ||||||||
| Modified residue | 554 | 1 | Phosphoserine; by MARK1, BRSK1, BRSK2 and PHK Ref.13 Ref.15 | ||||||||
| Modified residue | 577 | 1 | Phosphoserine; by PHK By similarity | ||||||||
| Modified residue | 581 | 1 | Phosphoserine; by PHK By similarity | ||||||||
| Modified residue | 585 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 597 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 616 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 644 | 1 | Phosphoserine; by PHK By similarity | ||||||||
| Modified residue | 648 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 688 | 1 | Phosphoserine; by CK1 and PDPK1 Ref.11 Ref.16 Ref.17 Ref.18 Ref.19 | ||||||||
| Modified residue | 692 | 1 | Phosphoserine Ref.11 Ref.16 Ref.17 Ref.18 Ref.19 | ||||||||
| Modified residue | 695 | 1 | Phosphothreonine Ref.11 Ref.16 Ref.17 | ||||||||
| Modified residue | 696 | 1 | Phosphoserine; by CK1 and PDPK1 Ref.10 Ref.11 Ref.16 Ref.18 | ||||||||
| Modified residue | 701 | 1 | Phosphoserine Ref.10 Ref.19 | ||||||||
| Modified residue | 704 | 1 | Phosphoserine Ref.11 | ||||||||
| Modified residue | 706 | 1 | Phosphothreonine Ref.10 Ref.11 | ||||||||
| Modified residue | 708 | 1 | Phosphoserine Ref.10 | ||||||||
| Modified residue | 714 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 719 | 1 | Phosphothreonine By similarity | ||||||||
| Disulfide bond | 583 ↔ 614 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 34 – 91 | 58 | Missing in isoform Tau-B, isoform Tau-C, isoform Tau-D and isoform Tau-E. | VSP_003185 | |||||||
| Alternative sequence | 92 – 113 | 22 | Missing in isoform Tau-E. | VSP_003186 | |||||||
| Alternative sequence | 114 – 350 | 237 | Missing in isoform Tau-A, isoform Tau-B, isoform Tau-C, isoform Tau-D and isoform Tau-E. | VSP_003187 | |||||||
| Alternative sequence | 368 – 433 | 66 | Missing in isoform Tau-A, isoform Tau-B, isoform Tau-C, isoform Tau-D and isoform Tau-E. | VSP_003188 | |||||||
| Alternative sequence | 567 – 597 | 31 | Missing in isoform Tau-B and isoform Tau-C. | VSP_003189 | |||||||
| Alternative sequence | 733 | 1 | L → KAALLSSQVWNYSHDLATIT DLGL in isoform Tau-B. | VSP_003190 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 3 | 1 | D → N Ref.1 | ||||||||
| Sequence conflict | 9 | 1 | D → N Ref.1 | ||||||||
| Sequence conflict | 405 | 1 | S → C in CAM14797. Ref.5 | ||||||||
| Sequence conflict | 528 | 1 | P → T in CAA78121. Ref.2 | ||||||||
| Sequence conflict | 549 | 1 | R → G in AAH14748. Ref.6 | ||||||||
| Sequence conflict | 672 | 1 | E → Q Ref.1 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Primary structure of high molecular weight tau present in the peripheral nervous system." Couchie D., Mavilia C., Georgieff I.S., Liem R.K.H., Shelanski M.L., Nunez J. Proc. Natl. Acad. Sci. U.S.A. 89:4378-4381(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PNS-TAU). Tissue: Neuroblastoma. |
| [2] | "Expression of three- and four-repeat tau isoforms in mouse liver." Kenner L., el-Shabrawi Y., Hutter H., Forstner M., Zatloukal K., Hoefler G., Preisegger K.-H., Kurzbauer R., Denk H. Hepatology 20:1086-1089(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-A; TAU-D AND TAU-E). Strain: Him OF1. Tissue: Brain, Kidney and Liver. |
| [3] | "The primary structure and heterogeneity of tau protein from mouse brain." Lee G., Cowan N.J., Kirschner M. Science 239:285-288(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-B AND TAU-C). Tissue: Brain. |
| [4] | "Molecular diversity at the carboxyl terminus of human and rat tau." Sawa A., Oyama F., Matsushita M., Ihara Y. Brain Res. Mol. Brain Res. 27:111-117(1994) [PubMed] [Europe PMC] [Abstract] Cited for: PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORM TAU-B). Strain: ICR. Tissue: Brain. |
| [5] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TAU-D). Tissue: Eye. |
| [7] | Lubec G., Sunyer B., Chen W.-Q. Submitted (JAN-2009) to UniProtKB Cited for: PROTEIN SEQUENCE OF 504-513; 535-546; 591-609 AND 646-661, MASS SPECTROMETRY. Strain: OF1. Tissue: Hippocampus. |
| [8] | "High molecular weight tau proteins and acquisition of neuronal polarity in peripheral nervous system." Couchie D., Gache Y., Mavilia C., Guilleminot J., Bridoux A.-M., Nivez M.-P., Nunez J. C. R. Acad. Sci. III, Sci. Vie 316:404-409(1993) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION. |
| [9] | "Phosphorylation of tau by fyn: implications for Alzheimer's disease." Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., Do L.H., Andreadis A., Van Hoesen G., Ksiezak-Reding H. J. Neurosci. 24:2304-2312(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY FYN. |
| [10] | "Phosphoproteomic analysis of the developing mouse brain." Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P. Mol. Cell. Proteomics 3:1093-1101(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696; SER-701; THR-706 AND SER-708, MASS SPECTROMETRY. Tissue: Embryonic brain. |
| [11] | "Proteomic analysis of in vivo phosphorylated synaptic proteins." Collins M.O., Yu L., Coba M.P., Husi H., Campuzano I., Blackstock W.P., Choudhary J.S., Grant S.G. J. Biol. Chem. 280:5972-5982(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-490; SER-491; SER-494; SER-688; SER-692; THR-695; SER-696; SER-704 AND THR-706, MASS SPECTROMETRY. Tissue: Forebrain. |
| [12] | "Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation." Babu J.R., Geetha T., Wooten M.W. J. Neurochem. 94:192-203(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PSMC2. |
| [13] | "Mammalian SAD kinases are required for neuronal polarization." Kishi M., Pan Y.A., Crump J.G., Sanes J.R. Science 307:929-932(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-554. |
| [14] | "Comprehensive identification of phosphorylation sites in postsynaptic density preparations." Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L. Mol. Cell. Proteomics 5:914-922(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-523 AND SER-527, MASS SPECTROMETRY. Tissue: Brain. |
| [15] | "LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons." Barnes A.P., Lilley B.N., Pan Y.A., Plummer L.J., Powell A.W., Raines A.N., Sanes J.R., Polleux F. Cell 129:549-563(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-554. |
| [16] | "A differential phosphoproteomic analysis of retinoic acid-treated P19 cells." Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D. J. Proteome Res. 6:3174-3186(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-457; SER-490; SER-491; SER-494; THR-497; SER-688; SER-692; THR-695 AND SER-696, MASS SPECTROMETRY. Tissue: Teratocarcinoma. |
| [17] | "Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations." Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., Panse C., Schlapbach R., Mansuy I.M. Mol. Cell. Proteomics 6:283-293(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-470; THR-473; TYR-489; SER-494; THR-497; SER-688; SER-692 AND THR-695, MASS SPECTROMETRY. Tissue: Brain cortex. |
| [18] | "Large-scale phosphorylation analysis of mouse liver." Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-491; SER-688; SER-692 AND SER-696, MASS SPECTROMETRY. Tissue: Liver. |
| [19] | "Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry." Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J., Faessler R., Mann M. J. Proteome Res. 7:5314-5326(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-523; SER-688; SER-692 AND SER-701, MASS SPECTROMETRY. Tissue: Melanoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U12914 mRNA. Translation: AAA58343.1. U12915 mRNA. Translation: AAA58344.1. U12916 mRNA. Translation: AAA58345.1. Z12133 mRNA. Translation: CAA78121.1. M93266 mRNA. No translation available. M18775 mRNA. Translation: AAA40165.1. M18776 mRNA. Translation: AAA40166.1. D30627 Genomic DNA. Translation: BAA18878.1. AL593843 Genomic DNA. Translation: CAM14797.1. BC014748 mRNA. Translation: AAH14748.1. |
| IPI | IPI00230408. IPI00331265. IPI00407807. IPI00465469. IPI00468678. IPI00649104. |
| PIR | A28820. A45301. B28820. |
| RefSeq | NP_001033698.1. NM_001038609.1. NP_034968.3. NM_010838.3. |
| UniGene | Mm.1287. |
3D structure databases | |
| ProteinModelPortal | P10637. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P10637. 2 interactions. |
| MINT | MINT-3974107. |
PTM databases | |
| PhosphoSite | P10637. |
Proteomic databases | |
| PaxDb | P10637. |
| PRIDE | P10637. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000100347; ENSMUSP00000097919; ENSMUSG00000018411. ENSMUST00000106988; ENSMUSP00000102601; ENSMUSG00000018411. ENSMUST00000106992; ENSMUSP00000102605; ENSMUSG00000018411. |
| GeneID | 17762. |
| KEGG | mmu:17762. |
| UCSC | uc011yga.1. mouse. |
Organism-specific databases | |
| CTD | 4137. |
| MGI | MGI:97180. Mapt. |
Phylogenomic databases | |
| eggNOG | NOG148882. |
| GeneTree | ENSGT00530000063491. |
| HOVERGEN | HBG000991. |
| KO | K04380. |
| OrthoDB | EOG4B8JDC. |
Gene expression databases | |
| ArrayExpress | P10637. |
| Bgee | P10637. |
| CleanEx | MM_MAPT. |
| Genevestigator | P10637. |
| GermOnline | ENSMUSG00000018411. Mus musculus. |
Family and domain databases | |
| InterPro | IPR027324. MAP2/MAP4/Tau. IPR001084. Tau/MAP_tubulin-bd_rpt. IPR002955. Tau_protein. [Graphical view] |
| PANTHER | PTHR11501. PTHR11501. 1 hit. |
| Pfam | PF00418. Tubulin-binding. 4 hits. [Graphical view] |
| PRINTS | PR01261. TAUPROTEIN. |
| PROSITE | PS00229. TAU_MAP_1. 4 hits. PS51491. TAU_MAP_2. 4 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | MAPT. mouse. |
| NextBio | 292453. |
| SOURCE | Search... |
Entry information
| Entry name | TAU_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P10637 Secondary accession number(s): A2A5Y9 Q91WK4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
